AMDWX
Price
$13.50
Change
-$0.22 (-1.60%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

AMDWX vs RNWFX

Header iconAMDWX vs RNWFX Comparison
Open Charts AMDWX vs RNWFXBanner chart's image
Amana Developing World Investor
Price$13.50
Change-$0.22 (-1.60%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AMDWX vs RNWFX Comparison Chart
Loading...
VS
AMDWX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMDWX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. AMDWX (128M). RNWFX pays higher dividends than AMDWX: RNWFX (1.51) vs AMDWX (0.84). AMDWX was incepted earlier than RNWFX: AMDWX (15 years) vs RNWFX (22 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. AMDWX (6.00). AMDWX has a lower initial minimum investment than RNWFX: AMDWX (100) vs RNWFX (250). AMDWX annual gain was more profitable for investors over the last year : 15.85 vs. RNWFX (11.53). AMDWX return over 5 years is better than : 42.38 vs. RNWFX (22.38).
AMDWXRNWFXAMDWX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years22 years-
Gain YTD9.6727.245133%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets128M60.1B0%
Annual Yield % from dividends0.841.5156%
Returns for 1 year15.8511.53137%
Returns for 3 years0.89-15.44-6%
Returns for 5 years42.3822.38189%
Returns for 10 years24.4935.7169%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio